HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sekiguchi, M. Articles by Amagai, M. Search for Related Content PubMed PubMed Citation Articles by Sekiguchi, M. Articles by Amagai, M.

Dominant Autoimmune Epitopes Recognized by Pemphigus Antibodies Map to the N-Terminal Adhesive Region of Desmogleins¹

Maiko Sekiguchi^*,, Yuko Futei^*, Yoshiko Fujii^*, Toshiro Iwasaki, Takeji Nishikawa^* and Masayuki Amagai^2,*

^* Department of Dermatology, Keio University School of Medicine, Tokyo, Japan; and Department of Internal Medicine, Faculty of Veterinary Medicine, Tokyo University of Agriculture and Technology, Tokyo, Japan

Desmoglein (Dsg) is a cadherin-type adhesion molecule found in desmosomes. Dsg1 and Dsg3 are the target Ags in the autoimmune blistering diseases pemphigus foliaceus (PF) and pemphigus vulgaris (PV), respectively. To map conformational epitopes of Dsg1 and Dsg3 in PF and PV, we generated Dsg1- and Dsg3-domain-swapped molecules and point-mutated Dsg3 molecules with Dsg1-specific residues by baculovirus expression. The swapped domains were portions of the N-terminal extracellular domains of Dsg1 (1–496) and Dsg3 (1–566), which have similar structures but distinct epitopes. The binding of autoantibodies to the mutant molecules was assessed by competition ELISAs. Domain-swapped molecules containing the N-terminal 161 residues of Dsg1 and Dsg3 yielded >50% competition in 30/43 (69.8%) PF sera and 31/40 (77.5%) PV sera, respectively. Furthermore, removal of Abs against the 161 N-terminal residues of Dsg1 by immunoadsorption eliminated the ability of PF sera to induce cutaneous blisters in neonatal mice. Within these N-terminal regions, most of the epitopes were mapped to residues 26–87 of Dsg1 and 25–88 of Dsg3. Furthermore, a point-mutated Dsg3 molecule containing Dsg1-specific amino acid substitutions (His²⁵, Cys²⁸, Ala²⁹) reacted with anti-Dsg1 IgG, thus defining one of the epitopes of Dsg1. Using the predicted three-dimensional structure of classic cadherins as a model, these findings suggest that the dominant autoimmune epitopes in both PF and PV are found in the N-terminal adhesive surfaces of Dsgs.

This article has been cited by other articles:

				T. Ota, M. Aoki-Ota, K. Tsunoda, T. Nishikawa, S. Koyasu, and M. Amagai Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance Int. Immunol., October 1, 2008; 20(10): 1351 - 1360. [Abstract] [Full Text] [PDF]

				W.-M. Heupel, D. Zillikens, D. Drenckhahn, and J. Waschke Pemphigus Vulgaris IgG Directly Inhibit Desmoglein 3-Mediated Transinteraction J. Immunol., August 1, 2008; 181(3): 1825 - 1834. [Abstract] [Full Text] [PDF]

				P. Joly, H. Mouquet, J.-C. Roujeau, M. D'Incan, D. Gilbert, S. Jacquot, M.-L. Gougeon, C. Bedane, R. Muller, B. Dreno, et al. A Single Cycle of Rituximab for the Treatment of Severe Pemphigus N. Engl. J. Med., August 9, 2007; 357(6): 545 - 552. [Abstract] [Full Text] [PDF]

				Y. Yamamoto, Y. Aoyama, E. Shu, K. Tsunoda, M. Amagai, and Y. Kitajima Anti-desmoglein 3 (Dsg3) Monoclonal Antibodies Deplete Desmosomes of Dsg3 and Differ in Their Dsg3-depleting Activities Related to Pathogenicity J. Biol. Chem., June 15, 2007; 282(24): 17866 - 17876. [Abstract] [Full Text] [PDF]

				H. Mouquet, S. Farci, P. Joly, B. Maillere, J. Leblond, L. Drouot, J. Leprince, M. C. Tonon, P. Loiseau, D. Charron, et al. A Truncated Alternative Spliced Isoform of Human Desmoglein 1 Contains a Specific T Cell Epitope Binding to the Pemphigus Foliaceus-Associated HLA Class II DRbeta1*0102 Molecule J. Immunol., November 1, 2006; 177(9): 6517 - 6526. [Abstract] [Full Text] [PDF]

				M. D. Kottke, E. Delva, and A. P. Kowalczyk The desmosome: cell science lessons from human diseases. J. Cell Sci., March 1, 2006; 119(Pt 5): 797 - 806. [Abstract] [Full Text] [PDF]

				S. Thoma-Uszynski, W. Uter, S. Schwietzke, G. Schuler, L. Borradori, and M. Hertl Autoreactive T and B Cells from Bullous Pemphigoid (BP) Patients Recognize Epitopes Clustered in Distinct Regions of BP180 and BP230 J. Immunol., February 1, 2006; 176(3): 2015 - 2023. [Abstract] [Full Text] [PDF]

				C. M. Veldman, K. L. Gebhard, W. Uter, R. Wassmuth, J. Grotzinger, E. Schultz, and M. Hertl T Cell Recognition of Desmoglein 3 Peptides in Patients with Pemphigus Vulgaris and Healthy Individuals J. Immunol., March 15, 2004; 172(6): 3883 - 3892. [Abstract] [Full Text] [PDF]

				S. Ortiz-Urda, A. Elbe-Burger, J. Smolle, Y. Marquart, Y. Chudnovsky, T. W. Ridky, P. Bernstein, K. Wolff, and K. Rappersberger The Plant Lectin Wheat Germ Agglutinin Inhibits the Binding of Pemphigus Foliaceus Autoantibodies to Desmoglein 1 in a Majority of Patients and Prevents Pathomechanisms of Pemphigus Foliaceus In Vitro and In Vivo J. Immunol., December 1, 2003; 171(11): 6244 - 6250. [Abstract] [Full Text] [PDF]

				N. Li, V. Aoki, G. Hans-Filho, E. A. Rivitti, and L. A. Diaz The Role of Intramolecular Epitope Spreading in the Pathogenesis of Endemic Pemphigus Foliaceus (Fogo Selvagem) J. Exp. Med., June 2, 2003; 197(11): 1501 - 1510. [Abstract] [Full Text] [PDF]

				K. Tsunoda, T. Ota, M. Aoki, T. Yamada, T. Nagai, T. Nakagawa, S. Koyasu, T. Nishikawa, and M. Amagai Induction of Pemphigus Phenotype by a Mouse Monoclonal Antibody Against the Amino-Terminal Adhesive Interface of Desmoglein 3 J. Immunol., February 15, 2003; 170(4): 2170 - 2178. [Abstract] [Full Text] [PDF]